We are live on ! Find out more
USNA icon

Usana Health Sciences

151 hedge funds and large institutions have $859M invested in Usana Health Sciences in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 51 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

38% more capital invested

Capital invested by funds: $621M → $859M (+$238M)

5% more funds holding

Funds holding: 144151 (+7)

3.81% more ownership

Funds ownership: 44.55%48.36% (+3.8%)

0% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 51

44% less call options, than puts

Call options by funds: $1.53M | Put options by funds: $2.73M

Holders
151
Holders Change
+7
Holders Change %
+4.86%
% of All Funds
3.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
51
Reduced
51
Closed
15
Calls
$1.53M
Puts
$2.73M
Net Calls
-$1.19M
Net Calls Change
-$1.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$6.18M -$91.8K -1,373 -2%
Morgan Stanley
27
Morgan Stanley
New York
$5.68M +$1.4M +20,888 +37%
TCIM
28
TIAA CREF Investment Management
New York
$5.39M -$749K -11,191 -13%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$5.1M +$334K +4,996 +8%
Russell Investments Group
30
Russell Investments Group
United Kingdom
$4.6M +$2.41M +35,993 +141%
AQR Capital Management
31
AQR Capital Management
Connecticut
$4.57M -$265K -3,967 -6%
CCMH
32
Cornerstone Capital Management Holdings
New York
$4.49M +$1.85M +27,700 +84%
FL
33
Fort LP
Maryland
$3.87M +$3.44M +51,474 +7,199%
SCA
34
Secor Capital Advisors
New York
$3.49M +$2.78M +41,542 +751%
AllianceBernstein
35
AllianceBernstein
Tennessee
$3.39M +$1.96M +29,230 +176%
AIMCA
36
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.38M +$1.97M +29,400 +180%
Ameriprise
37
Ameriprise
Minnesota
$3.31M -$86.2K -1,288 -3%
CEI
38
Clark Estates Inc
New York
$3.27M
HSBC Holdings
39
HSBC Holdings
United Kingdom
$3.13M +$1.63M +24,297 +135%
HA
40
Hays Advisory
Tennessee
$3.04M -$1.16M -17,410 -30%
Goldman Sachs
41
Goldman Sachs
New York
$2.69M -$882K -13,180 -27%
GC
42
Guggenheim Capital
Illinois
$2.62M +$24.2K +362 +1%
MAM
43
Martingale Asset Management
Massachusetts
$2.59M -$174K -2,598 -7%
Federated Hermes
44
Federated Hermes
Pennsylvania
$2.48M -$13.4K -200 -0.6%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$2.47M +$2.12M +31,669 +1,806%
GCP
46
GSA Capital Partners
United Kingdom
$2.47M +$1.51M +22,522 +208%
GH
47
GAM Holding
Switzerland
$2.37M +$2.14M +32,002 New
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$2.16M -$335K -5,005 -15%
Bank of America
49
Bank of America
North Carolina
$2.15M +$1.87M +28,010 +2,563%
PPA
50
Parametric Portfolio Associates
Washington
$1.92M +$44K +658 +3%

USNA Hedge Fund Activity: Q4 2017 in Review

151 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2017, worth a combined $859M — up 38% from $621M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 15 closed out — a net gain of 9 holders — while 51 added to existing stakes and 51 trimmed.

The largest buyer was DZ Bank, adding an estimated $9.34M. The largest seller was Fidelity Investments, cutting an estimated $3.27M.

  • 151 institutional investors held Usana Health Sciences (USNA) as of Q4 2017, up from 144 in Q3 2017.
  • Funds reported $859M of Usana Health Sciences stock for Q4 2017, up 38% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q4 2017 and 15 closed out, a net change of +9 holders.
  • The largest Usana Health Sciences buyer in Q4 2017 was DZ Bank, an estimated $9.34M added.
  • The largest Usana Health Sciences seller in Q4 2017 was Fidelity Investments, an estimated $3.27M sold.

Based on aggregated 13F filings for Q4 2017.